Titanium Media App reported on August 9th that the General Office of the Ministry of Industry and Information Technology, the General Office of the National Health Commission, the Office of the National Medical Security Administration, and the General Department of the State Drug Administration issued a statement on strengthening the shortage of drugs and the state-organized centralized procurement of selected drugs. Notice of production reserve monitoring work. Local industry and information technology authorities, together with health, medical security, and drug regulatory authorities, urge and guide monitoring companies in the region to fill in production reserve information online, and coordinate and organize production and supply. The Ministry of Industry and Information Technology, together with relevant departments, analyzes production reserve information, conducts inspections and assessments in a timely manner, publishes relevant information, and coordinates and solves major problems.
media coverage
Titanium Media 36Kr
Related events
- Four departments: Strengthen the monitoring of shortage drugs and the production and storage of selected drugs in the centralized procurement of drugs organized by the state 2022-08-09
- State Food and Drug Administration: Coordinate emergency approval and quality supervision to speed up the research and development of new coronavirus treatment drugs2022-07-25
- Beijing Medical Insurance Bureau responded to the call out of the supplementary list of drugs, and only deleted a certain dosage form in the related drugs2022-07-20
- 141 kinds of drugs will be transferred out of Beijing Medical Insurance by the end of the year2022-07-18
- The seventh batch of national procurement: 61 drug varieties open bids in Nanjing today2022-07-12
This article is reprinted from: https://readhub.cn/topic/8ikPFY3zrPN
This site is for inclusion only, and the copyright belongs to the original author.